Montelukast and Neuropsychiatric Events in Children With Asthma: A Nested Case-Control Study
نویسندگان
چکیده
منابع مشابه
prevalence of atopic dermatitis in children with type 1 diabetes mellitus in southeastern of iran (kerman province): a case-control study
چکیده ندارد.
15 صفحه اولDetermine Efficacy of a Short Course of Montelukast in Children with Intermittent Asthma and Viral Infection
Introduction Mild intermittent asthma is common in children and viral infections are responsible for the majority of exacerbations. As leukotrienes are potent inflammatory mediators, some studies have shown that Montelukast, a leukotriene receptor antagonist, may be effective on reduction of asthma symptom. To determine whether a short course of Montelukast in asthmatic children with common col...
متن کاملSerum C-reactive protein in asthma and its ability in predicting asthma control, a case-control study
Background: Increased serum high sensitive C-reactive protein (hs-CRP) in asthma and its association with disease severity has been investigated in many studies. This study aimed to determine serum hs-CRP status in asthma versus healthy controls and to examine its ability in predicting asthma control. Methods: Serum CRP was measured by ELISA method using a high sensitive CRP kit. Severity...
متن کاملNeuropsychiatric adverse effects of montelukast in children
Asthma is the most common chronic disease of childhood. It is associated with significant morbidity and costs including missed time from school and work for children and their parents. For those children ⩾5 years of age with persistent symptoms or frequent exacerbations, inhaled corticosteroids (ICS) provide an effective and safe treatment, at least at low doses. However, parents are often conc...
متن کاملMontelukast moderately decreased asthma symptoms in children with persistent asthma.
Patients 689 children who were 2 to 5 years of age (mean age 4 y, 59% boys, 56% white), had > 3 episodes of asthma symptoms in the previous year, had a total asthma symptom score > 1 (of 24) for > 8 days during the 2 week placebo baseline period, and used â agonists for > 8 days during the placebo baseline period. Exclusion criteria included asthma intubation and emergency department treatment ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatrics
سال: 2020
ISSN: 0031-4005,1098-4275
DOI: 10.1542/peds.2020-023861dddd